CD44 and cancer: In summary, compared with previous studies that considered CD44 as a marker of CSCs, our study speculated that CD44 may promote the tumor immunosuppressive microenvironment by affecting myeloid cells in the TME, such as the differentiation of myeloid cells, the interaction between monocytes and other cells, the maintenance of M2 polarization which promote the progression of cancer.